Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05377450 · ClinicalTrials.gov registry record · NA

Prospective Randomized Study of Cementless vs Cemented UKA

A NA study of Osteoarthritis, Knee, sponsored by JIS Research Institute.

Active
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT05377450 is a NA study of Osteoarthritis, Knee that is active but no longer recruiting, run by JIS Research Institute. The registered enrollment target is 108 participants, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05377450, a NA study of Osteoarthritis, Knee, is active but no longer recruiting, sponsored by JIS Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

To evaluate the non-inferiority of the cementless Engage Partial Knee System compared to cemented Engage Partial knee System.

Conditions Studied

Interventions

  • DEVICE Engage Partial Knee

Study Locations (1)

Ohio

  • JIS Research Institute - New Albany

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2022-08-29
Est. Completion 2025-05
Phase NA

Sponsor

JIS Research Institute

1 total trials

What the Registry Record Tells You About NCT05377450

The ClinicalTrials.gov registry entry for NCT05377450 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (81% lower). The listed sponsor is JIS Research Institute, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Engage Partial Knee is the first listed.

NCT05377450 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05377450 about?

NCT05377450 is a clinical study titled "Prospective Randomized Study of Cementless vs Cemented UKA". To evaluate the non-inferiority of the cementless Engage Partial Knee System compared to cemented Engage Partial knee System.

What is the current status of trial NCT05377450?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2022-08-29. Estimated completion is 2025-05.

What conditions does trial NCT05377450 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT05377450?

The interventions under investigation include: Engage Partial Knee (DEVICE).

Who is sponsoring clinical trial NCT05377450?

This trial is sponsored by JIS Research Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05377450 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.